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Direct Left Atrial MitraClip Delivery via a
Novel Port Access ApproachRakesh M. Suri, MD, DPHIL,*y Joseph F. Malouf, MD,yz Vuyisile T. Nkomo, MD, MPH,z Erica D. Wittwer, MD, PHD,x
Richard C. Daly, MD,y Charanjit S. Rihal, MD, MBAzW e describe a novel method of MitraClip(Abbott Vascular, Santa Clara, California)delivery via the right superior pulmo-
nary vein in a patient with an impassable interatrial
septum. The patient had a history of 2 median ster-
notomies for coronary artery revascularization and
aortic valve replacement. He presented with New
York Heart Association functional class IV symptoms
and congestive heart failure associated with severeFIGURE 1 Thickened Lipomatous Interatrial Septum After
Failed Percutaneous Transseptal Passage
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prolapse. The patient had multiple comorbidities
including paroxysmal atrial ﬁbrillation, chronic
pleural effusions, and dialysis-dependent renal
failure and was thus deemed to be an unsuitableFIGURE 2 Port-Access Approach After Direct Puncture of the
Right Superior Pulmonary Vein
Close-up image of small right chest fourth intercostal space port
through which the MitraClip delivery system (Abbott Vascular,
Santa Clara, California) is inserted.
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FIGURE 3 2-Dimensional Transesophageal Echocardiography
Using a 51’ Commissural View Demonstrating a Flail Med-
ical Scallop of the Posterior Mitral Leaﬂet
FIGURE 5 3-Dimensional Transesophageal Echocardiography
Demonstrating the MitraClip Delivery Sheath (Abbott
Vascular, Santa Clara, California) Inserted Via the Right
Superior Pulmonary Vein Through the Mitral Oriﬁce and
Just Into the Left Ventricle
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e184candidate for third time repeat sternotomy and mitral
valve repair. Owing to the existence of a thickened
septum caused by marked lipomatous hypertrophy
(Figure 1) and unsuccessful crossing attempts associ-
ated with inadvertent puncture of the pulmonary
artery, direct left atrial access for MitraClip delivery
was considered. We describe the technical features
of the procedure during which a right chest, fourth
intercostal space miniport was fashioned (Figure 2),
and emergency wire access for cardiopulmonary
bypass support was prophylactically secured via theFIGURE 4 3-Dimensional Transesophageal Echocardiography
Documneting Posterior Leaﬂet Prolapse and Dual Jets of
Mitral Regurgitation Posteromedially and Centrallyright common femoral vessels. Two-dimensional
transesophageal echocardiography (TEE) suggested a
ﬂail medial scallop of the posterior mitral leaﬂet
(Figure 3), which was conﬁrmed using 3-dimensional
TEE (Figure 4). Using a Seldinger technique via a
thoracoscopically placed purse-string suture at the
junction of the right superior pulmonary vein and
left atrium, the MitraClip delivery sheath was directly
inserted just through the mitral valve oriﬁce
(Figure 5). The ﬁrst of 2 MitraClip devices wereFIGURE 6 3-Dimensional Transesophageal Echocardiography
Demonstrating the First MitraClip Device (Abbott Vascular,
Santa Clara, California) Positioned Over the Posteromedial
Prolapsing Segment
FIGURE 7 3-Dimensional Transesophageal Echocardiography
Demonstrating the Second MitraClip Device (Abbott
Vascular, Santa Clara, California) Delivered Between the
Middle Scallops of the Anterior and Posterior Leaﬂets
FIGURE 8 2-Dimensional Transesophageal Echocardiography
Demonstrating Mild Residual Mitral Regurgitation After
Delivery of 2 MitraClip Devices (Abbott Vascular, Santa
Clara, California)
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e185delivered (Figure 6) to correct posteromedial scallop
prolapse. Residual MR necessitated the delivery of a
second device through the same MitraClip sheath
held stable in position during loading of the second
device (Figure 7). TEE demonstrated the diminution
of severe mitral regurgitation to mild after delivery
of both MitraClip devices (Figure 8), after which the
sheath was removed and the pulmonary vein purse
string tied to secure hemostasis.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Rakesh M. Suri, Department of Thoracic and Cardio-
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